Consolidated Balance Sheets (unaudited) - USD ($) shares in Thousands, $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 175,726	$ 163,637
Accounts receivable, net of allowance for doubtful accounts of $14,336 and $15,161, respectively	3,087,105	3,272,371
Inventories	265,570	265,154
Other current assets	217,415	199,506
Total current assets	3,745,816	3,900,668
Property and equipment, net of accumulated depreciation and amortization of $215,418 and $214,981, respectively	200,969	204,260
Goodwill	493,724	493,033
Intangible assets, net of accumulated amortization of $146,893 and $142,297, respectively	196,879	204,998
Other assets	323,140	309,622
Total assets	4,960,528	5,112,581
Current liabilities:
Accounts payable—trade	1,711,878	1,785,076
Accounts payable—inventory financing facilities	410,126	301,314
Accrued expenses and other current liabilities	415,519	433,789
Current portion of long-term debt	346,672	346,228
Total current liabilities	2,884,195	2,866,407
Long-term debt	168,875	291,672
Deferred income taxes	28,728	32,844
Other liabilities	305,132	283,590
Total liabilities	3,386,930	3,474,513
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.01 par value, 3,000 shares authorized; no shares issued	0	0
Common stock, $0.01 par value, 100,000 shares authorized; 33,261 shares at March 31, 2023 and 34,009 shares at December 31, 2022 issued and outstanding	333	340
Additional paid-in capital	317,283	327,872
Retained earnings	1,310,178	1,368,658
Accumulated other comprehensive loss – foreign currency translation adjustments	(54,196)	(58,802)
Total stockholders’ equity	1,573,598	1,638,068
Total liabilities and stockholders' equity	$ 4,960,528	$ 5,112,581
Common stock, shares issued (in shares)	33,261	34,009
Common stock, shares outstanding (in shares)	33,261	34,009